Release of cardiac biochemical and inflammatory markers in patients on cardiopulmonary bypass undergoing coronary artery bypass grafting

Journal of Cardiac Surgery

Volumn 23, Issue 6, 2008, Pages 681-687

  Meng, Qing H ^a   Zhu, Shiming ^a   Sohn, Namseok ^a   Mycyk, Taras ^a   Shaw, Susan A ^a   Dalshaug, Greg ^a   Krahn, John ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CERULOPLASMIN; CREATINE KINASE; GLUCOSE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LACTIC ACID; PROTEIN AAT; REPRESSOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIET RESTRICTION; ELECTIVE SURGERY; GENERAL ANESTHESIA; HUMAN; INFLAMMATION; PROTEIN BLOOD LEVEL; REVASCULARIZATION;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; COHORT STUDIES; CORONARY ARTERY BYPASS; CREATINE KINASE, MB FORM; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; LACTIC ACID; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; TROPONIN I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 55149123167     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2008.00701.x     Document Type: Article

References (45)

1. Lehrke S, Steen H, Sievers HH, et al : Cardiac troponin T for prediction of short- and long-term morbidity and mortality after elective open heart surgery. Clin Chem 2004 50 : 1560 1567.
2. Bonnefoy E, Filley S, Kirkorian G, et al : Troponin I, troponin T, or creatine kinase-MB to detect perioperative myocardial damage after coronary artery bypass surgery. Chest 1998 114 : 482 486.
3. Jacquet L, Noirhomme P, El Khoury G, et al : Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery. Eur J Cardiothorac Surg 1998 13 : 378 384.
4. Taggart DP : Biochemical assessment of myocardial injury after cardiac surgery: Effects of a platelet activating factor antagonist, bilateral internal thoracic artery grafts, and coronary endarterectomy. J Thorac Cardiovasc Surg 2000 120 : 651 659.
5. Alpert JS, Thygesen K, Antman E, et al : Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. JACC 2000 36 : 959 969.
6. Palmerini T, Marzocchi A, Marrozzini C, et al : Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. Eur J Cardiothorac Surg 2007 31 : 685 690.
7. Jaffe AS, Ravkilde J, Roberts R, et al : It is time for a change to a troponin standard. Circulation 2000 102 : 1216 1220.
8. Greenson N, Macoviak J, Krishnaswamy P, et al : Usefulness of cardiac troponin I in patients undergoing open heart surgery. Am Heart J 2001 141 : 447 455.
9. Immer FF, Stocker F, Seiler AM, et al : Troponin-I for prediction of early postoperative course after pediatric surgery. JACC 1999 33 : 1719 1723.
10. Koh TW, Hooper J, Kemp M, et al : Intraoperative release of troponin T in coronary venous and arterial blood and its relation to recovery of left ventricular function and oxidative metabolism following coronary artery surgery. Heart 1998 80 : 341 348.
11. Fellahi JL, Gue X, Richomme X, et al : Short-and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 2003 99 : 270 274.
12. Quaniers JM, Leruth J, Albert A, et al : Comparison of inflammatory responses after off-pump and on-pump coronary surgery using surface modifying additives circuit. Ann Thorac Surg 2006 81 : 1683 1690.
13. Levy JH, Tanaka KA : Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003 75 : S715 S720.
14. Wan S, LeClerc JL, Vincent JL : Cytokine responses to cardiopulmonary bypass - lessons learned from cardiac transplantation. Ann Thorac Surg 1997 63 : 269 276.
15. Hennein HA, Ebba H, Rodriguez JL, et al : Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994 108 : 626 635.
16. Wan S, DeSmet JM, Barvais L, et al : Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996 112 : 806 811.
17. Etievent JP, Chocron S, Toubin G, et al : Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg 1995 59 : 1192 1194.
18. Vermes E, Mesguich M, Houel R, et al : Cardiac troponin I release after open heart surgery: A marker of myocardial protection? Ann Thorac Surg 2000 70 : 2087 2090.
19. Paparella D, Cappabianca G, Visicchio G, et al : Cardiac troponin I release after coronary artery bypass grafting operation: Effects on operative and midterm survival. Ann Thorac Surg 2005 80 : 1758 1764.
20. Teoh KH, Bradley CA, Gauldie J, et al : Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation 1995 92 : II347 II353.
21. Engstrom G, Hedblad B, Stavenow L, et al : Fatality of future coronary events is related to inflammation-sensitive plasma proteins: A population-based prospective cohort study. Circulation 2004 110 : 27 31.
22. Lind P, Engstrom G, Stavenow L, et al : Risk of myocardial infarction and stroke in smokers is related to plasma levels of inflammation-sensitive proteins. Arterioscler Thromb Vasc Biol 2004 24 : 577 582.
23. Engstrom G, Lind P, Hedblad B, et al : Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation 2002 105 : 2632 2637.
24. Momin A, Melikia N, Wheatcroft SB, et al : The association between saphenous vein endothelial function, systemic inflammation, and statin therapy in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007 134 : 335 341.
25. Morrow DA, Cannon CP, Jesse RL, et al : National academy of clinical biochemistry laboratory medicine practice guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 2007 53 : 552 574.
26. Kathiresan S, Servoss SJ, Newell JB, et al : Cardiac troponin T elevation after coronary artery bypass grafting is associated with increased one-year mortality. Am J Cardiol 2004 94 : 879 881.
27. Onorati F, De Feo M, Mastroroberto P, et al : Determinants and prognosis of myocardial damage after coronary artery bypass grafting. Ann Thorac Surg 2005 79 : 837 845.
28. Salamonsen RF, Schneider HG, Bailey M, et al : Cardiac troponin I concentrations, but not electrocardiographic results, predict an extended hospital stay after coronary artery bypass graft surgery. Clin Chem 2005 51 : 40 46.
29. Bimmel D, Patermann B, Schlosser T, et al : Do we still need CK-MB in coronary artery bypass grafting surgery? J Cardiovasc Surg (Torino) 2003 44 : 191 196.
30. Noora J, Ricci C, Hastings D, et al : Determination of troponin I release after CABG surgery. J Card Surg 2005 20 : 129 135.
31. Kovacevic R, Majkic-Singh N, Ignjatovic S, et al : Troponin T levels in detection of perioperative myocardial infarction after coronary artery bypass surgery. Clin Lab 2004 50 : 437 445.
32. Karu I, Loit R, Paapstel A, et al : Early postoperative function of the heart after coronary artery bypass grafting is not predicted by myocardial necrosis and glutathione-associated oxidative stress. Clin Chim Acta 2005 359 : 195 202.
33. Carrier M, Pellerin M, Perrault LP, et al : Troponin levels in patients with myocardial infarction after coronary bypass grafting. Ann Thorac Surg 2000 69 : 435 440.
34. Sadony V, Korber M, Albes G, et al : Cardiac troponin I plasma levels for diagnosis and quantitation of perioperative myocardial damage in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 1998 13 : 57 65.
35. Horvath KA, Parker MA, Frederiksen JW, et al : Postoperative troponin I values: Insult or injury? Clin Cardiol 2000 23 : 731 733.
36. Wan S, Izzat MB, Lee TW, et al : Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury. Ann Thorac Surg 1999 68 : 52 56.
37. Costa MA, Carere RG, Lichtenstein SV, et al : Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS). Circulation 2001 104 : 2689 2693.
38. Abu-Omar Y, Taggart DP : Off-pump coronary artery bypass grafting. Lancet 2002 360 : 327 330.
39. Khan NE, De Souza A, Mister R, et al : A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med 2004 350 : 21 28.
40. Karaca P, Konuralp C, Enc Y, et al : Cardioprotective effect of aprotinin on myocardial ischemia/reperfusion injury during cardiopulmonary bypass. Circ J 2006 70 : 1432 1436.
41. Colagrande L, Formica F, Porta F, et al : Reduced cytokines release and myocardial damage in coronary artery bypass patients due to L-arginine cardioplegia supplementation. Ann Thorac Surg 2006 81 : 1256 1261.
42. Franke A, Lante W, Fackeldey V, et al : Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: Is what we see what we know? Eur J Cardiothorac Surg 2005 28 : 569 575.
43. Celik JB, Gormus N, Okesli S, et al : Methylprednisolone prevents inflammatory reaction occurring during cardiopulmonary bypass: Effects on TNF-alpha, IL-6, IL-8, IL-10. Perfusion 2004 19 : 185 191.
44. Sharma M, Ganguly NK, Chaturvedi G, et al : Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery. Mol Cell Biochem 2003 247 : 23 30.
45. Paparella D, Al Radi OO, Meng QH, et al : The effects of high-dose heparin on inflammatory and coagulation parameters following cardiopulmonary bypass. Blood Coagul Fibrinolysis 2005 16 : 323 328.